1,277
Views
34
CrossRef citations to date
0
Altmetric
Review

Medication Therapy Management: Current Challenges

ORCID Icon, &
Pages 71-81 | Published online: 02 Apr 2020

References

  • Gray C. Evolution of the medicare Part D medication therapy management program from inception in 2006 to the present. Am Health Drug Benefits. 2019;12(5):243.32015791
  • Medication-management-services-definition-and-key-points-version-1.pdf. Available from: https://jcpp.net/wp-content/uploads/2018/05/Medication-Management-Services-Definition-and-Key-Points-Version-1.pdf. Accessed 129, 2019.
  • Stewart D, Whittlesea C, Dhital R, Newbould L, McCambridge J. Community pharmacist led medication reviews in the UK: a scoping review of the medicines use review and the new medicine service literatures. Res Soc Adm Pharm. 2019. doi:10.1016/j.sapharm.2019.04.010
  • Henrich N, Tsao N, Gastonguay L, Lynd L, Marra CA. BC medication management project. Can Pharm J CPJ. 2015;148(2):90–100. doi:10.1177/1715163515569571
  • Chen TF. Pharmacist-led home medicines review and residential medication management review: the Australian model. Drugs Aging Auckl. 2016;33(3):199–204. doi:10.1007/s40266-016-0357-2
  • Zagaria MAE, Chris Alderman. Community-based medication management in the U.S. and Australia. Available from: https://www.uspharmacist.com/article/community-based-medication-management-in-the-us-and-australia. Accessed 1111, 2019.
  • Bluml BM. Definition of medication therapy management: development of profession wide consensus. JAPhA. 2005;45(5):566–572. doi:10.1331/154434505500127416295641
  • American Pharmacists Association. National Association of Chain Drug Stores Foundation. Medication therapy management in community pharmacy practice: core elements of an MTM service (version 1.0). JAPhA. 2005;45(5):573–579. doi:10.1331/1544345055001256.16295642
  • American Pharmacists Association. National Association of Chain Drug Stores Foundation. Medication therapy management in pharmacy practice: core elements of an MTM service model (version 2.0). JAPhA. 2008;48(3):341–353. doi:10.1331/JAPhA.2008.08514.18595820
  • Snyder ME, Jaynes HA, Gernant SA, Lantaff WM, Hudmon KS, Doucette WR. Variation in medication therapy management delivery: implications for health care policy. J Manag Care Spec Pharm. 2018;24(9):896–902. doi:10.18553/jmcp.2018.24.9.89630156453
  • Olinger L, Fair S, Mercincavage L, Stratos S Daniella Perlroth Grecia Marrufo Alejandro Montesinos Catherine Lewis Anjali Dixit Bingbing Li Emil Rusev Ekta Ghimire Michael Packard.:242.
  • Bacci JL, Bigham KA, Dillon‐Sumner L, et al. Community pharmacist patient care services: a systematic review of approaches used for implementation and evaluation. JACCP. 2019;2(4):423–432. doi:10.1002/jac5.1136
  • Adeoye OA, Farley JF, Coe AB, et al. Medication therapy management delivery by community pharmacists: insights from a national sample of medicare Part D beneficiaries. JACCP. 2019;2(4):373–382. doi:10.1002/jac5.1160
  • Onwuegbuzie AJ. 7 Steps to a Comprehensive Literature Review: A Multimodal & Cultural Approach. London: SAGE Publications; 2016.
  • Smith MG, Ferreri SP, Brown P, Wines K, Shea CM, Pfeiffenberger TM. Implementing an integrated care management program in community pharmacies: a focus on medication management services. J Am Pharm Assoc. 2017;57(2):229–235.e1. doi:10.1016/j.japh.2016.12.074
  • Houle SKD, Charrois TL, Faruquee CF, Tsuyuki RT, Rosenthal MM. A randomized controlled study of practice facilitation to improve the provision of medication management services in Alberta community pharmacies. Res Soc Adm Pharm. 2017;13(2):339–348. doi:10.1016/j.sapharm.2016.02.013
  • Blake KB, Madhavan SS, Scott VG, Meredith Elswick BL. Medication therapy management services in West Virginia: pharmacists’ perceptions of educational and training needs. RSAP. 2009;5(2):182–188. doi:10.1016/j.sapharm.2008.06.00319524865
  • Smith MG, Shea CM, Brown P, Wines K, Farley JF, Ferreri SP. Pharmacy characteristics associated with the provision of medication management services within an integrated care management program. JAPhA. 2017;57(2):217–221.e1. doi:10.1016/j.japh.2016.12.07328173992
  • Adeoye OA, Lake LM, Lourens SG, Morris RE, Snyder ME. What predicts medication therapy management completion rates? The role of community pharmacy staff characteristics and beliefs about medication therapy management. JAPhA. 2018;58(4S):S7–S15.e5. doi:10.1016/j.japh.2018.03.00129731422
  • Jorgenson D, Dalton D, Farrell B, Tsuyuki RT, Dolovich L. Guidelines for pharmacists integrating into primary care teams. Can Pharm J CPJ. 2013;146(6):342–352. doi:10.1177/1715163513504528
  • Leung HY, Saini B, Ritchie HE. Medications and pregnancy: the role of community pharmacists - a descriptive study. PLoS One. 2018;13(5):e0195101. doi:10.1371/journal.pone.019510129742159
  • Lounsbery JL, Green CG, Bennett MS, Pedersen CA. Evaluation of pharmacists’ barriers to the implementation of medication therapy management services. JAPhA. 2009;49(1):51–58. doi:10.1331/JAPhA.2009.01715819196597
  • Branham AR, Katz AJ, Moose JS, Ferreri SP, Farley JF, Marciniak MW. Retrospective analysis of estimated cost avoidance following pharmacist-provided medication therapy management services. J Pharm Pract. 2013;26(4):420–427. doi:10.1177/089719001246599223178415
  • Burnside TPT, Scott NJ, Smith MG. Implementation of technician driven medication therapy management program in community pharmacies. J Am Pharm Assoc. 2019;59(4):S156–S160.e2. doi:10.1016/j.japh.2019.06.014
  • Hohmeier KC, McDonough SLK, Rein LJ, Brookhart AL, Gibson ML, Powers MF. Exploring the expanded role of the pharmacy technician in medication therapy management service implementation in the community pharmacy. JAPhA. 2019;59(2):187–194. doi:10.1016/j.japh.2018.11.00630679031
  • Isetts B. Integrating Medication Therapy Management (MTM) services provided by community pharmacists into a community-based Accountable Care Organization (ACO). Pharm Basel Switz. 2017;5:4. doi:10.3390/pharmacy5040056
  • Hattingh HL, Kelly F, Fowler J, Wheeler AJ. Implementation of a mental health medication management intervention in Australian community pharmacies: facilitators and challenges. RSAP. 2017;13(5):969–979. doi:10.1016/j.sapharm.2017.05.01728583302
  • Domiati S, Sacre H, Lahoud N, Sili G, Salameh P. Knowledge of and readiness for medication therapy management among community pharmacists in Lebanon. Int J Clin Pharm. 2018;40(5):1165–1174. doi:10.1007/s11096-018-0666-029858761
  • Hattingh HL, Emmerton L, Ng Cheong Tin P, Green C. Utilization of community pharmacy space to enhance privacy: a qualitative study. Health Expect Int J Public Particip Health Care Health Policy. 2016;19(5):1098–1110. doi:10.1111/hex.12401
  • Smith MA, Spiggle S, McConnell B. Strategies for community-based medication management services in value-based health plans. Res Soc Adm Pharm. 2017;13(1):48–62. doi:10.1016/j.sapharm.2016.01.005
  • Redmond P, Carroll H, Grimes T, et al. GPs’ and community pharmacists’ opinions on medication management at transitions of care in Ireland. Fam Pract. 2016;33(2):172–178. doi:10.1093/fampra/cmw00626984995
  • Lee CY, Goeman D, Beanland C, Elliott RA. Challenges and barriers associated with medication management for home nursing clients in Australia: a qualitative study combining the perspectives of community nurses, community pharmacists and GPs. Fam Pract. 2019;36(3):332–342. doi:10.1093/fampra/cmy07330184123
  • Michaels NM, Jenkins GF, Pruss DL, Heidrick JE, Ferreri SP. Retrospective analysis of community pharmacists’ recommendations in the North Carolina Medicaid medication therapy management program. JAPhA. 2010;50(3):347–353. doi:10.1331/JAPhA.2010.0902120452907
  • Tewksbury A, Bozymski KM, Ruekert L, Lum C, Cunningham E, Covington F. Development of collaborative drug therapy management and clinical pharmacy services in an outpatient psychiatric clinic. J Pharm Pract. 2018;31(3):272–278. doi:10.1177/089719001771052128539104
  • Haga SB, Allen LaPointe NM, Moaddeb J. Challenges to integrating pharmacogenetic testing into medication therapy management. J Manag Care Spec Pharm. 2015;21(4):346–352. doi:10.18553/jmcp.2015.21.4.34625803768
  • Maidment ID, Aston L, Moutela T, Fox CG, Hilton A. A qualitative study exploring medication management in people with dementia living in the community and the potential role of the community pharmacist. Health Expect Int J Public Particip Health Care Health Policy. 2017;20(5):929–942. doi:10.1111/hex.12534
  • Bosworth HB, Zullig LL, Mendys P, et al. Health information technology: meaningful use and next steps to improving electronic facilitation of medication adherence. JMIR Med Inform. 2016;4(1):e9. doi:10.2196/medinform.432626980270
  • Newsome J. Virtual medication therapy management: the cornerstone to a pharmacy renaissance. JAPhA. 2013;53(2):159–162. doi:10.1331/JAPhA.2013.1218823571623
  • Ma C, Smith HW, Chu C, Juarez DT. Big data in pharmacy practice: current use, challenges, and the future. Int Pharm Res Pract. 2015;4:91. doi:10.2147/IPRP.S55862.
  • Turner K, Renfro C, Ferreri S, Roberts K, Pfeiffenberger T, Shea CM. Supporting community pharmacies with implementation of a web-based medication management application. Appl Clin Inform. 2018;9(2):391–402. doi:10.1055/s-0038-165148829847843
  • Millonig MK. Mapping the route to medication therapy management documentation and billing standardization and interoperabilility within the health care system: meeting proceedings. JAPhA. 2009;49(3):372–382. doi:10.1331/JAPhA.2008.0951819357067
  • Isetts BJ, Schondelmeyer SW, Artz MB, et al. Clinical and economic outcomes of medication therapy management services: the Minnesota experience. J Am Pharm Assoc. 2008;48(2):203–214. doi:10.1331/JAPhA.2008.07108
  • Smith M, Cannon-Breland ML, Spiggle S. Consumer, physician, and payer perspectives on primary care medication management services with a shared resource pharmacists network. RSAP. 2014;10(3):539–553. doi:10.1016/j.sapharm.2013.08.00324055137
  • Rosenquist A, Best BM, Miller TA, Gilmer TP, Hirsch JD. Medication therapy management services in community pharmacy: a pilot programme in HIV specialty pharmacies. J Eval Clin Pract. 2010;16(6):1142–1146. doi:10.1111/j.1365-2753.2009.01283.x21143346
  • Schnur ES, Adams AJ, Klepser DG, Doucette WR, Scott DM, PCMHs A. medication management: lessons learned from early research partnerships. J Manag Care Pharm JMCP. 2014;20(2):201–205. doi:10.18553/jmcp.2014.20.2.20124456322
  • Garcia GM, Snyder ME, McGrath SH, Smith RB, McGivney MS. Generating demand for pharmacist-provided medication therapy management: identifying patient-preferred marketing strategies. JAPhA. 2009;49(5):611–616. doi:10.1331/JAPhA.2009.0808919748867
  • Hong SH, Liu J, Wang J, Brown L, White-Means S. Conjoint analysis of patient preferences on Medicare medication therapy management. JAPhA. 2011;51(3):378–387. doi:10.1331/JAPhA.2011.1003921555290
  • Blake KB, Madhavan SS. Perceived barriers to provision of medication therapy management services (MTMS) and the likelihood of a pharmacist to work in a pharmacy that provides MTMS. Ann Pharmacother. 2010;44(3):424–431. doi:10.1345/aph.1M38620179254
  • Rucker NL. Medicare Part D’s Medication Therapy Management: Shifting from Neutral to Drive. AARP Public Policy Institute 2012; 12.
  • Balick R. Patients cheer a Minnesota-based MTM program. Pharm Today. 2018;24(3):46–47. doi:10.1016/j.ptdy.2018.02.029
  • Pestka DL, Zillich AJ, Coe AB, et al. Nationwide estimates of medication therapy management delivery under the Medicare prescription drug benefit. JAPhA. 2020. doi:10.1016/j.japh.2019.12.002
  • Turner K, Weinberger M, Renfro C, et al. Stages of change: moving community pharmacies from a drug dispensing to population health management model. MCRR. 2019;2019:1077558719841159. doi:10.1177/1077558719841159.
  • Angelo LB, Ferreri SP. Assessment of workflow redesign in community pharmacy. JAPhA. 2005;45(2):145–150. doi:10.1331/154434505362347415868756
  • Gernant SA, Zillich AJ, Snyder ME. Access to medical records’ impact on community pharmacist–delivered medication therapy management: a pilot from the medication safety research network of indiana (Rx-SafeNet). J Pharm Pract. 2018;31(6):642–650. doi:10.1177/089719001773542229017421
  • Renfro CP, Turner K, Desai R, Counts J, Shea CM, Ferreri SP. Implementation process for comprehensive medication review in the community pharmacy setting. JAPhA. 2019;59(6):836–841.e2. doi:10.1016/j.japh.2019.07.00731405803
  • Timothy P, Frost, Adams AJ. Pharmacist and technician perceptions of tech-check-tech in community pharmacy practice settings. J Pharm Pract. 2018;31(2):190–194.28393657
  • Isasi F, Krofah E The expanding role of pharmacists in a transformed health care system - center for pharmacy practice accreditation. Available from: https://www.pharmacypracticeaccredit.org/resources/the-expanding-role-of-pharmacists-in-a-transformed-health-care-system. Accessed 11 16, 2019.
  • Smith M, Bates DW, Bodenheimer T, Cleary PD. Why pharmacists belong in the medical home. Health Aff (Millwood). 2010;29(5):906–913. doi:10.1377/hlthaff.2010.020920439879
  • Pringle JL, Boyer A, Conklin MH, McCullough JW, Aldridge A. The Pennsylvania Project: pharmacist intervention improved medication adherence and reduced health care costs. Health Aff Proj Hope. 2014;33(8):1444–1452. doi:10.1377/hlthaff.2013.1398
  • Luder HR, Shannon P, Kirby J, Frede SM. Community pharmacist collaboration with a patient-centered medical home: establishment of a patient-centered medical neighborhood and payment model. JAPhA. 2018;58(1):44–50. doi:10.1016/j.japh.2017.10.00629153853
  • Ferreri SP. Strategies to set up shared EHR use between community pharmacies and primary care practices. Pharm Today. 2018;24(4):41. doi:10.1016/j.ptdy.2018.03.026
  • Turner K, Weinberger M, Renfro C, et al. The role of network ties to support implementation of a community pharmacy enhanced services network. RSAP. 2019;15(9):1118–1125. doi:10.1016/j.sapharm.2018.09.01530291004
  • Pezzino NC, Marciniak MW, Smith MG, Ferreri SP. Physician-reported factors that encourage collaboration with community pharmacists. JAPhA. 2017;57(3S):S279–S283.e2. doi:10.1016/j.japh.2017.02.01628411013
  • Snyder ME, Zillich AJ, Primack BA, et al. Exploring successful community pharmacist-physician collaborative working relationships using mixed methods. RSAP. 2010;6(4):307–323. doi:10.1016/j.sapharm.2009.11.00821111388
  • Fay AE, Ferreri SP, Shepherd G, Lundeen K, Tong GL, Pfeiffenberger T. Care team perspectives on community pharmacy enhanced services. JAPhA. 2018;58(4S):S83–S88.e3. doi:10.1016/j.japh.2018.05.00930006190
  • Smith MG, Ferreri SP. A model to inform community pharmacy’s collaboration in outpatient care. RSAP. 2016;12(3):529–534. doi:10.1016/j.sapharm.2015.07.00526314920
  • Vink J, Morton D, Ferreri S. Pharmacist identification of medication-related problems in the home care setting. Consult Pharm J Am Soc Consult Pharm. 2011;26(7):477–484. doi:10.4140/TCP.n.2011.477
  • Snyder ME, Earl TR, Gilchrist S, et al. Collaborative drug therapy management: case studies of three community-based models of care. Prev Chronic Dis. 2015;12. doi:10.5888/pcd12.140504.
  • Hammond RW, Schwartz AH, Campbell MJ, et al. Collaborative drug therapy management by pharmacists—2003. Pharmacother J Hum Pharmacol Drug Ther. 2003;23(9):1210–1225. doi:10.1592/phco.23.10.1210.32752
  • Bacci JL, Coley KC, McGrath K, Abraham O, Adams AJ, McGivney MS. Strategies to facilitate the implementation of collaborative practice agreements in chain community pharmacies. JAPhA. 2016;56(3):257–265.e2. doi:10.1016/j.japh.2016.02.01427053276
  • Glenn ZM, Mahdavian SL, Woodard TJ. Preparing to provide MTM services. J Pharm Pract. 2015;28(1):6–9. doi:10.1177/089719001456234925542865
  • Funk KA, Weaver KK. Team work and collaborative practice agreements among pharmacists and nurse practitioners. JAPhA. 2018;58(1):117–119. doi:10.1016/j.japh.2017.10.01629217143
  • Farley JF, Ferreri SP, Easter JC, McClurg MR. The North Carolina experiment: active research in the development and assessment of new practice models. N C Med J. 2017;78(3):186–190. doi:10.18043/ncm.78.3.18628576958
  • Armistead LT, Ferreri SP. Improving value through community pharmacy partnerships. Popul Health Manag. 2019;22(1):5–8. doi:10.1089/pop.2018.004029757078
  • Was this helpful? Available from: https://cmmicoordinator.survey.fm/was-this-helpful?iframe=https%3A%2F%2Finnovation.cms.gov%2Finitiatives%2Fenhancedmtm%2F&ft=1. Accessed 125, 2019.
  • DeBenedette V. Health information technology in the community pharmacy. Drug Topics. Available from https://www.drugtopics.com/chains-business/health-information-technology-community-pharmacy. Accessed 1111, 2019.
  • Bonner L. Pharmacists inch closer to accessing EHRs and HIEs. Pharm Today. 2016;22(5):44–47. doi:10.1016/j.ptdy.2016.04.031
  • Mantzourani E, Way CM, Hodson KL. Does an integrated information technology system provide support for community pharmacists undertaking discharge medicines reviews? An exploratory study. Integr Pharm Res Pract. 2017;6:145–156. doi:10.2147/IPRP.S13327329354561
  • Figge HLF. CLSSS Senior Sales Strategy Consultant, AllscriptsMysis Chairman, Task Force for Education and Publications Pharmacy Informatics Section, American Society of Health-System Pharmacists Clifton Park, New Using Technological Reducing Medication Errors Innovations. 2019;11 Available from: https://www.uspharmacist.com/article/reducing-medication-errors-using-technological-innovations-12633. Accessed 1111, 2020.
  • Fuji KT, Gait KA, Siracuse MV, Christoffersen JS. Electronic health record adoption and use by Nebraska pharmacists. Perspect Health Inf Manag AHIMA. 2011;8(Summer).
  • Renfro CP, Ferreri S, Barber TG, Foley S. Development of a communication strategy to increase interprofessional collaboration in the outpatient setting. Pharm Basel Switz. 2018;6:1. doi:10.3390/pharmacy6010004
  • Schafer KM, Gionfriddo MR, Boehm DH. Shared decision making and medication therapy management with the use of an interactive template. JAPhA. 2016;56(2):166–172. doi:10.1016/j.japh.2015.12.01327000167
  • Health information technology in the community pharmacy. Drug Topics. Published 2016 https://www.drugtopics.com/drug-topics/news/health-information-technology-community-pharmacy. Accessed 1116, 2019.
  • Patel PM, Vaidya V, Osundina F, Comoe DA. Determining patient preferences of community pharmacy attributes: a systematic review. JAPhA. 2019. doi:10.1016/j.japh.2019.10.008
  • Taylor AM, Axon DR, Campbell P, et al. What patients know about services to help manage chronic diseases and medications: findings from focus groups on medication therapy management. J Manag Care Spec Pharm. 2018;24(9):904–910. doi:10.18553/jmcp.2018.24.9.90430156456
  • Tomaszewski D, Cernohous T, Vaidyanathan R. Evaluating patient preferences for different incentive programs to optimize pharmacist-provided patient care program enrollment. J Manag Care Spec Pharm. 2017;23(11):1140–1147. doi:10.18553/jmcp.2017.23.11.114029083970
  • Shimp LA, Kucukarslan SN, Elder J, et al. Employer-based patient-centered medication therapy management program: evidence and recommendations for future programs. JAPhA. 2012;52(6):768–776. doi:10.1331/JAPhA.2012.1118623229963
  • Miguel A, Hall A, Liu W, et al. Improving comprehensive medication review acceptance by using a standardized recruitment script: a randomized control trial. J Manag Care Spec Pharm. 2017;23(1):13–21. doi:10.18553/jmcp.2017.23.1.1328025924
  • Denvir PM, Cardone KE, Parker WM, Cerulli J. How do I say that?”: using communication principles to enhance medication therapy management instruction. Curr Pharm Teach Learn. 2018;10(2):185–194. doi:10.1016/j.cptl.2017.10.01429706274
  • Angelo LB, Christensen DB, Ferreri SP. Impact of community pharmacy automation on workflow, workload, and patient interaction. JAPhA. 2005;45(2):138–144. doi:10.1331/154434505362353715868755
  • Nicole Brandt P. Evolution of the medicare Part D medication therapy management program from inception in 2006 to the present. 2019 Available from: http://www.ahdbonline.com/issues/2019/september-2019-vol-12-no-5/2844-evolution-of-the-medicare-part-d-medication-therapy-management-program-from-inception-in-2006-to-the-present. Accessed 1115, 2019.
  • Tong Z, Cooke CE, Brandt NJ. Online provision of Part D medication therapy management program information. J Manag Care Spec Pharm. 2019;25(8):898–903. doi:10.18553/jmcp.2019.25.8.89831347982
  • Brandt NJ, Cooke CE, Sharma K, et al. Findings from a national survey of medicare beneficiary perspectives on the medicare Part D medication therapy management standardized format. J Manag Care Spec Pharm. 2019;25(3):366–391. doi:10.18553/jmcp.2019.25.3.36630816816